Item 2.02 Results of Operations and Financial Condition.
On November 6, 2009, Par Pharmaceutical Companies, Inc. issued a press release
announcing its financial results for the third quarter ended October 3, 2009.
The Company's press release is furnished as Exhibit 99.1 to this Current Report
on Form 8-K.
The information in this Current Report on Form 8-K, including Exhibit 99.1, is
furnished pursuant to Item 2.02 and shall not be deemed "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise
subject to the liabilities of that Section, nor shall it be deemed incorporated
by reference in any filing under the Securities Act of 1933, as amended, except
as shall be expressly set forth by specific reference in such filing.
Item 9.01
Add
PRX to Portfolio
Set Alert
Email to a
Friend